Murchinson’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-75,000
Closed -$2.54M 158
2021
Q2
$2.54M Buy
+75,000
New +$1.91M 0.91% 31

Murchinson's CNST Position: Q3 2021 in Review

Murchinson sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 75,000 shares — an estimated $2.54M sold.

Murchinson first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $2.54M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Murchinson reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Murchinson sold 75,000 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.54M.
  • Murchinson first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Murchinson's Constellation Pharmaceuticals, Inc. position peaked at $2.54M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Murchinson's 13F filing for Q3 2021, filed 15 Nov 2021.